Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in Endocrine Related Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
ER
Endocrine-Related Cancer is a journal focused on endocrine-related cancer research. It publishes accepted manuscripts and special collections, has a 2024 Journal Impact Factor of 4.6 and a CiteScore of 8.1, and is available in print and online editions with ISSNs 1351-0088 and 1479-6821.
Looking to publish in Endocrine Related Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
Subject
Endocrinology & Metabolism, Oncology
Impact Factor
4.6
Quartile
Q1
Open Access Type
Hybrid
ISSN
1351-0088
eISSN
1479-6821
Invitation Only
No
Cost Range
Gold open access APC: £3000; £1500 for non-profit subscribers. Green open access is free. Corresponding authors at institutions with a Read and Publish deal may qualify for free gold open-access publication.
Submission Instructions
Endocrine Related Cancer accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Cover Letter
Research Articles must include statements on conflicts of interest, funding, and acknowledgements or author contributions in the separate title page document rather than the anonymised main manuscript.
Abstract
Research Articles must include an abstract. The abstract must be a single paragraph of no more than 250 words. The abstract must be unstructured as a single paragraph. The abstract must state the study objective, methods where applicable, and summarise results and conclusions without using abbreviations or references.
Manuscript
Research Articles are limited to 6,000 words unless otherwise specified. Research Articles must include the sections Title Page, Abstract, Introduction, Materials and methods, Results, Discussion, Declaration of interest, Funding and Acknowledgements, References, Tables, and Figures. Research Articles must include at least four keywords, a generative AI disclosure statement, and a Data Availability Statement.
References
Research Articles should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in citation order and include at least three authors before 'et al.' is used.
Figures & Tables
Manuscripts should contain no more than 10 figures, and large tables should be submitted as supplementary materials. The title page must be uploaded separately from the anonymised main manuscript. Figures and tables must be anonymised, numbered in the order cited, and accompanied by legends or titles.
Reviews
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract requirements are not specified.
Manuscript
Reviews must be limited to 6,000 words. Reviews should include the sections used in the Preparation of Manuscripts guidance. The manuscript must include a generative AI disclosure statement, including the specified no-use statement if no generative AI tools were used.
References
Reviews must have a maximum of 60 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, and at least three authors must be listed before using 'et al.'.
Figures & Tables
Reviews must have a maximum of 10 figures and tables. Figures and tables must be anonymised and must not include any reference to author affiliations.
Mini Reviews
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract requirements are not specified.
Manuscript
Mini Reviews must be no more than 3000 words in length. A statement disclosing whether generative AI was used must be included in the manuscript, and if none was used it must state: “No generative Artificial Intelligence (AI) tools were used in the preparation of the written or visual content of this manuscript.”
References
Mini Reviews must have 30 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text and include at least three authors before using 'et al.'.
Figures & Tables
Mini Reviews must have 5 figures.
Systematic Reviews
Cover Letter
Cover Letter requirements are not specified.
Abstract
Systematic Reviews must include an abstract. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Purpose, Methods, Results and Conclusions.
Manuscript
Systematic Reviews must be limited to 6,000 words. The manuscript must include Title page, Abstract, Introduction, Materials and Methods, Results, Discussion, Declaration of interest, Funding and Acknowledgments, Data sharing or availability statement, References, Tables, and figures. The abstract and Materials and Methods section should include a statement confirming adherence to PRISMA, and the manuscript must include a generative AI use statement.
References
References should not exceed 60. References must be cited in Vancouver style. References must be numbered in citation order and list at least three authors before using 'et al.'.
Figures & Tables
Figures should not exceed 10. The title page must be uploaded separately, but no explicit placement rule is stated for figures and tables. Tables and figures must be numbered in the order they are cited in the text, and figures, tables, and legends must not include author affiliations.
Clinical Review: Approach To Patient With Endocrine Tumour
Cover Letter
Cover Letter requirements are not specified.
Abstract
An abstract is required. Abstract must be up to 250 words.
Manuscript
Manuscript must be up to 5000 words. Manuscript must include the sections Introduction, Future directions, Conclusion, and References, and the Introduction must cover disease overview and clinical significance. Manuscript must include a statement disclosing whether generative AI was used in preparing the written or visual content, and if none was used it must state that no generative Artificial Intelligence tools were used.
References
References must not exceed 60. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, all cited references must appear in the reference list and vice versa, web-only sources must be cited in the text with access date and omitted from the reference list, unpublished work must be cited only in the text, and at least three authors must be listed before using 'et al.'.
Figures & Tables
There must be no more than 6 figures or tables. Figures and tables must be numbered in the order cited in the text and must not include any reference to author affiliations.
Letters To The Editor
Cover Letter
A formal proposal must be submitted to the editorial office before submission and must include a proposed outline, a brief explanation of timeliness and value to the current literature, a brief explanation of relevance to readers, and a one- or two-page CV and publication record for the past 5 years for all authors or valid ORCID IDs with publication histories updated for at least the past 5 years.
Abstract
Abstract is not allowed for Letters To The Editor.
Manuscript
Letters To The Editor must be no longer than 1500 words. Letters To The Editor must comment on papers published in this journal within the last 12 months and be written in a neutral tone. The manuscript must include a generative AI use statement, and supplementary data is not allowed.
References
Letters To The Editor must have no more than 10 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text and must list at least three authors before using 'et al.'.
Figures & Tables
Letters To The Editor must have no figures or tables.
Case Reports
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract requirements are not specified.
Manuscript
Manuscript must not exceed 6,000 words. Manuscript must include a statement disclosing whether generative AI was used, and if used must list the name, version, model, and source, or otherwise state that no generative AI tools were used in preparing the written or visual content.
References
Reference list should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, all text citations and reference-list entries must correspond, and at least three authors must be listed before using 'et al.'.
Figures & Tables
Manuscript should contain no more than 10 figures. Figures and tables must be numbered in the order they are cited in the text, and figures, tables, and legends must not include any reference to author affiliations.
Case Series
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract requirements are not specified.
Manuscript
Manuscript must not exceed 6,000 words. Manuscript must include a statement disclosing whether generative AI was used in preparing the written or visual content, and if none was used it must state: “No generative Artificial Intelligence (AI) tools were used in the preparation of the written or visual content of this manuscript.”
References
Reference list should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in citation order and include at least three authors before using 'et al.'.
Figures & Tables
Manuscript should contain no more than 10 figures. Figures and tables must be numbered in the order they are cited in the text, and figures, tables, and legends must not include any reference to author affiliations.
Endocrine Tumour In Focus
Cover Letter
Cover Letter requirements are not specified.
Abstract
An abstract is required. Abstract must be no more than 200 words.
Manuscript
Manuscript must be no more than 4000 words. Manuscript must include the sections Introduction, Knowledge gaps and future directions, Conclusion, and References. Manuscript must include a statement disclosing whether generative AI was used, and if not used it must state: “No generative Artificial Intelligence (AI) tools were used in the preparation of the written or visual content of this manuscript.”
References
Reference list must contain no more than 40 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text and must list at least three authors before using 'et al.'.
Figures & Tables
Manuscript must have no more than 4 figures or tables. Figures and tables must be numbered in the order they are cited in the text and must not include any reference to author affiliations.
Guidelines And Recommendations
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract requirements are not specified.
Manuscript
Manuscripts must be limited to 6,000 words. Manuscripts must clearly describe the authors’ and society’s roles, the literature search and review approach with dates and consistency, a DELPHI-based consensus method, and evidence quality assessment and scoring for the final recommendations. Manuscripts must include a generative AI disclosure statement and should clearly delineate the recommendation scoring system and approach, preferably with a table.
References
Manuscripts should contain no more than 60 references. References must be cited numerically in Vancouver style. References must be listed in the order cited in the text, with at least three authors named before using 'et al.'.
Figures & Tables
Manuscripts should contain no more than 10 figures. Figures and tables must be numbered in the order they are cited in the text, and figures, tables, and legends must not include any reference to author affiliations.
Recent Publications
Applying 177Lu-Dotatate for Hereditary Neuroendocrine Tumours: The Role in MEN1
Morticia N. Becx, Mark J.C. van Treijen, Tessa Brabander, Wouter W. de Herder, Arthur J.A.T. Braat, Richard A. Feelders, Julie Nonnekens, Johannes Hofland
10.1530/erc-25-0514
View Publication
Effects of a GLP-1 agonist and anti-diabetic therapies on pheochromocytoma/paraganglioma growth
Katharina Wang, Priska Stempfle, Julia Hamati, Alessa Fischer, Umberto Maccio, Achim Weber, Mercedes Robledo, Julian Maurer, Lea Peischer, Astrid Reul, Elena Kuzmenko, Alexander Huber, Diana Vetter, Jose Oberholzer, Nicole Reisch, Petra Zimmermann, Thomas Knösel, Matthias K Auer, Christian Lottspeich, Felix Beuschlein, Constanze Hantel, Ashley B Grossman, Karel Pacak, Kathrin Zitzmann, Christoph J Auernhammer, Svenja Nölting
10.1530/erc-26-0283
View Publication
Potential for pathogenic protein acylation in succinate dehydrogenase-deficient pheochromocytoma and paraganglioma
Sherry X. Zhou, L. James Maher
10.1530/erc-26-0243
View Publication
Cancer-Associated Fibroblasts Drive Papillary Thyroid Cancer Progression through ROS/NF-κB/IL-6 Signaling in Hypoxic Microenvironment
Hongjun Song, Xianzhao Deng, Chentian Shen, Yang Wang, Chuang Xi, Yunyun Zhu, Jian Wang, Quanyong Luo, Zhongling Qiu
10.1530/erc-26-0198
View Publication
MIB2-mediated ubiquitination of HK2 inhibits glycolysis in PTC
Lijun Zhang, Houchao Tong, Chengyuan Li, Jianing Zhou, Jingsheng Cai, Haisheng Fang, Jianfei Wen, Xiang Zhang, Heda Zhang, Meiping Shen, Yong Wang, Yan Si
10.1530/erc-26-0049
View Publication
Frequently asked questions
How long does it take to publish?
On average the journal returns a decision on a peer-reviewed paper in 18 days.
Reformat to Endocrine Related Cancer using Livewrite PremiumIs a cover letter required?
A cover letter should introduce the paper and explain why the work is important and suitable for publication at this time.
Reformat to Endocrine Related Cancer using Livewrite PremiumWhat are the publication costs?
Gold open access APC is £3000 for Endocrine-Related Cancer, with a £1500 rate for non-profit subscribers. Green open access is free. Authors at institutions with a Read and Publish deal may qualify for free gold open-access publication.
Reformat to Endocrine Related Cancer using Livewrite PremiumResearch Topics
Neuroendocrine Tumor Research Advances
Thyroid Cancer Diagnosis and Treatment
Estrogen and related hormone effects
Adrenal and Paraganglionic Tumors
Cancer, Hypoxia, and Metabolism
Neuroblastoma Research and Treatments
Prostate Cancer Treatment and Research
Pituitary Gland Disorders and Treatments
Lung Cancer Research Studies
Cancer-related Molecular Pathways
Growth Hormone and Insulin-like Growth Factors
Metabolism, Diabetes, and Cancer
HER2/EGFR in Cancer Research
Hormonal Regulation and Hypertension
Pancreatic and Hepatic Oncology Research
BRCA gene mutations in cancer
Cancer Risks and Factors
Cancer Cells and Metastasis
PI3K/AKT/mTOR signaling in cancer
Cancer, Lipids, and Metabolism
Breast Cancer Treatment Studies
Thyroid Disorders and Treatments
Glioma Diagnosis and Treatment
Epigenetics and DNA Methylation
Cytokine Signaling Pathways and Interactions
Related Journals
BA
Blood and Lymphatic Cancer Targets and Therapy
Dove Medical Press
TA
Therapeutic Advances in Endocrinology and Metabolism
SAGE Publishing
RA
Reproduction and Fertility
Bioscientifica
BJ
British Journal of Cancer
Springer Nature
CC
Current Cancer Drug Targets
Bentham Science Publishers
FI
Frontiers in Endocrinology
Frontiers Media